Compile Data Set for Download or QSAR
maximum 50k data
Found 105 Enz. Inhib. hit(s) with all data for assayid = 2 entry = 9170
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446679(US10669289, Compound 86)
Affinity DataIC50:  275nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446629(US10669289, Compound 36)
Affinity DataIC50:  275nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446611(US10669289, Compound 18)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446612(US10669289, Compound 19)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446613(US10669289, Compound 20)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446616(US10669289, Compound 23)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446617(US10669289, Compound 24)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446618(US10669289, Compound 25)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446619(US10669289, Compound 26)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446622(US10669289, Compound 29)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446624(US10669289, Compound 31)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446648(US10669289, Compound 55)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446662(US10669289, Compound 69)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446675(US10669289, Compound 82)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446681(US10669289, Compound 88)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446689(US10669289, Compound 96)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446693(US10669289, Compound 100)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446695(US10669289, Compound 102)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446696(US10669289, Compound 103)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446697(US10669289, Compound 104)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446595(US10669289, Compound 2)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446597(US10669289, Compound 4)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446600(US10669289, Compound 7)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446601(US10669289, Compound 8)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446602(US10669289, Compound 9)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446596(US10669289, Compound 10 | US10669289, Compound 3)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446604(US10669289, Compound 11)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446605(US10669289, Compound 12)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446606(US10669289, Compound 13)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446608(US10669289, Compound 15)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446610(US10669289, Compound 17)
Affinity DataIC50:  2.75E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446607(US10669289, Compound 14)
Affinity DataIC50: >5.00E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446609(US10669289, Compound 16)
Affinity DataIC50: >5.00E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446614(US10669289, Compound 21)
Affinity DataIC50: >5.00E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446615(US10669289, Compound 22)
Affinity DataIC50: >5.00E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446620(US10669289, Compound 27)
Affinity DataIC50: >5.00E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446621(US10669289, Compound 28)
Affinity DataIC50: >5.00E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446623(US10669289, Compound 30)
Affinity DataIC50: >5.00E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446625(US10669289, Compound 32)
Affinity DataIC50: >5.00E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446626(US10669289, Compound 33)
Affinity DataIC50: >5.00E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446627(US10669289, Compound 34)
Affinity DataIC50: >5.00E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446628(US10669289, Compound 35)
Affinity DataIC50: >5.00E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446630(US10669289, Compound 37)
Affinity DataIC50: >5.00E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446631(US10669289, Compound 38)
Affinity DataIC50: >5.00E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446632(US10669289, Compound 39)
Affinity DataIC50: >5.00E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446633(US10669289, Compound 40)
Affinity DataIC50: >5.00E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446634(US10669289, Compound 41)
Affinity DataIC50: >5.00E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446635(US10669289, Compound 42)
Affinity DataIC50: >5.00E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446636(US10669289, Compound 43)
Affinity DataIC50: >5.00E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteasome subunit beta type-5(Homo sapiens (Human))
Merck Patent

US Patent
LigandPNGBDBM446637(US10669289, Compound 44)
Affinity DataIC50: >5.00E+3nMAssay Description:Measurement of Beta5 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human constitutive proteasome (1.25 nM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 105 total ) | Next | Last >>
Jump to: